Related Experiment Video
Updated: Apr 15, 2026
07:47
Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
16.4K
Further available immunization option to prevent pneumococcal disease
1GSK Vaccines, Wavre, 1300, Belgium.
F1000Research
|April 14, 2015
Summary
Pneumococcal infections can be managed with the protein D pneumococcal conjugate vaccine (PHiD-CV). This WHO-pre-approved vaccine demonstrates significant impact supported by real-world data.
Area of Science:
- Medicine
- Immunology
- Infectious Diseases
Background:
- Pneumococcal infections pose a significant global health challenge.
- Existing reviews provide clinical overviews but may omit specific vaccine details.
Purpose of the Study:
- To supplement existing reviews on pneumococcal infections.
- To highlight the protein D pneumococcal conjugate vaccine (PHiD-CV) as a key immunization strategy.
Main Methods:
- Review of existing literature on pneumococcal infections.
- Inclusion of data pertaining to the protein D pneumococcal conjugate vaccine (PHiD-CV).
Main Results:
- The protein D pneumococcal conjugate vaccine (PHiD-CV) is a widely-used immunization option.
- PHiD-CV has received pre-approval from the World Health Organization (WHO).
- Real-life data confirms the vaccine's impact in regions where it is utilized.
Conclusions:
- The protein D pneumococcal conjugate vaccine (PHiD-CV) is a valuable tool in combating pneumococcal infections.
- PHiD-CV's efficacy is supported by empirical evidence and international endorsement.
More Related Videos
08:47Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
Published on: April 5, 2019
13.5K
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
15.8K
Related Concept Videos
01:30Pneumonia V: Nursing management and Prevention
4.1K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.1K
01:28Pneumonia IV: Management
1.1K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
01:30Pneumonia III: Complications and Assessment
1.3K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K
01:25Transmission-based Precautions II: Airborne and Protective Environment
2.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.2K
01:30Pneumonia I: Introduction
1.4K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
01:14Atypical Pneumonia
64
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
64